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Arterial hypertension (AH) and angiotensin II (AngII) induce a cardiovas-
cular remodelling involving hypertrophy and ¿ brosis. We hypothesize that 
aldosterone may disturb this remodelling.
We created AS- Ren mice by crossing mice overexpressing the aldosterone 
synthase (AS) gene in cardiomyocytes with RenTgKC+/- (Ren) mice overex-
pressing the renin gene in liver. AS male mice have an increased (x 2) intra-
cardiac aldosterone and are normotensive; Ren mice have increased plasmatic 
AngII and sustained AH.
Ren and AS- Ren mice had AH (+70%) versus their controls. HW/BW ratio 
and collagen staining showed a worsening of cardiac hypertrophy (+41%) and 
¿ brosis (+20%) in AS- Ren mice (P<0.05 vs Ren). The iincrease of BNP (x 
2.5; P<0.01) and ANP (x 2.5; P< 0.01) mRNAs seen in Ren mice heart was 
blunted in AS- Ren. This block may be involved in the higher cardiac hyper-
trophy of AS- Ren mice. Besides, the AH- induced increase of ßMyHC and its 
intronic miRNA- 208b was prevented in AS- Ren. The inhibition of miR 208a 
(- 75%, p<0.001) in AS- Ren mice compared to AS was associated with an 
increased Sox 6 mRNA (x 1.34; p<0.05) an inhibitor of ßMyHC transcription. 
Expression of pro¿ brotic CTGF and TGF- ß increased similarly (x 1.9; 
p<0.05) in Ren and AS- Ren mice. However, AS- Ren mice only had Cd68+ 
macrophages and enhanced Galectin- 3 expression in heart. Interestingly, in 
AS- Ren mice the AH- induced increase of the anti¿ brotic factor BMP4 was 
inhibited.
Finally, eplerenone decreased hypertrophy and ¿ brosis in AS- Ren mice. 
Indeed, MR antagonism reversed the AS- Ren mouse phenotype, allowing up- 
regulation of BNP, ANP and ßMyHC mRNAs and reduction of galectin- 3 and 
CD68.
Our data indicate that in AH, a cardiac hyperaldosteronism through MR- 
dependent pathways worsens the development of cardiac hypertrophy and 
¿ brosis by activating inÀ ammatory processes and inhibiting antitrophic and 
anti¿ brotic pathways.
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Introduction: Atrial ¿ brillation (AF) is usually the consequence of atrial 
remodeling due to increased left atrium (LA) afterload. Hypertensive cardio-
myopathy is the leading cause of AF. LA remodeling has been extensively 
studied, but small animal models of AF due to chronic LA remodeling are still 
lacking. Spontaneous hypertensive rats (SHR) are considered to be a good 
model of human hypertensive cardiomyopathy. We analyzed early LA remo-
deling of SHR.
Material and methods: We therefore compared three groups of rats: 
13 weeks old SHR (n=7), 26 weeks SHR (n=13) and 26 weeks Wistar 
Kyoto (normotensive controls, n=9). We performed trans- thoracic echo-
cardiography (TTE), 24 hours telemetry analysis (P- wave duration, atrial 
premature beats=APB), invasive right atrial stimulation (atrial effective 
refractory periods – AERP – and AF inducibility), histological (fibrosis 
quantification), immunohistochemical (connexins 43 location) and rt- PCR 
analysis.
Results and discussion: Hypertension induced left ventricular (LV) concen-
tric hypertrophy with diastolic dysfunction responsible for increased LA after-
load as assessed by LA ANP mRNA levels. This lead to LA dilatation on TTE, 
important LA ¿ brosis (¿ gure), connexin 43 delocalization, increased P- wave 
duration and APB. LA expression of pro¿ brotic factor CTGF and proin-
À ammatory factor Galectine 3 were markedly increased in SHR. However, 
AF inducibility was not different in SHR in comparison to WKY. In SHR, 
between 13 and 26 weeks, several LA remodeling parameters worsened: atrial 
¿ brosis (¿ gure), P- wave duration, number of APB, inducibility and duration of 
AF. Anatomical parameters of LA and LV were stable.
Conclusion: Severe hypertension induced early atrial remodeling. However, 
AF inducibility was not different in SHR in comparison to WKY. Between 13 
and 26 weeks, several parameters of LA remodeling worsened. Ef¿ ciency of 
drugs preventing early LA remodeling could be assessed using SHR between 
13 and 26 weeks of age.
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Introduction: Omega- 3 polyunsaturated fatty acids (PUFA) may prevent atrial 
¿ brillation (AF) through anti- inÀ ammatory, antioxidant, anti- ¿ brotic and anti-
arrhythmic properties. Discrepancies exist between experimental and clinical 
studies. Our hypothesis is that this drug may be ef¿ cient in preventing early atrial 
remodeling. We tested this hypothesis in an animal model of chronic hypertension.
Material and methods: We therefore worked on young spontaneous 
hypertensive rats (SHR) and their normotensive controls, WKY rats. We 
compared 4 groups of rats: WKY 26 weeks (n=9), SHR 13 weeks (n=7), 
untreated SHR 26 weeks (n=13) and SHR 26 weeks + PUFAs orally given 
between 13 and 26 weeks (n=11; Omacor® (P Fabre laboratories)=10mg/
kg/d). We analyzed left atrium (LA) remodeling in a multiparameter 
manner (trans- thoracic echocardiography, 24 hours telemetry analysis, inva-
sive right atrial stimulation, histological, immunohistochemical and rt- PCR 
analysis).
Results and discussion: Omega- 3 PUFAs markedly prevented LA ¿ brosis 
worsening and connexin 43 delocalization observed in untreated hypertensive 
rats between the age of 13 and 26 weeks (see ¿ gure). However, these PUFAs 
had no signi¿ cant impact on anatomic and electrophysiological LA remode-
ling parameters such as LA weight, P- wave duration or atrial effective refrac-
tory period. PUFAs did not reduce AF inducibility or duration during invasive 
atrial stimulations (AF duration: untreated SHR 26 weeks=5.26 +/- 2.2 seconds; 
PUFA SHR 26 weeks=5.27 +/- 2.5s, NS). Prevention of LA ¿ brosis was linked 
with a dramatic 51% decrease in pro¿ brotic factor CTGF expression in LA of 
treated rats.
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Conclusion: Omega- 3 PUFA prevented early histological LA remodeling 
but had no impact on anatomic or electrophysiological parameters. Longer or 
earlier treatment may have been more ef¿ cient on “macroscopic” parameters. 
These drugs may be ef¿ cient at the early stage of atrial remodeling, and pro-
bably useless in secondary prevention.
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Heart failure with preserved ejection fraction is characterized by a LV dias-
tolic dysfunction with an ejection fraction over 40%, observed in old hyperten-
sive (HBP) patients. Few experimental studies deeply investigated the diastolic 
function of SHRs. The left ventricle expresses 5- HT4R as well as 5- HT2aR and 
5- HT2bR overexpressed in cardiac hypertrophy due to aortic banding.
The aim of this work was to evaluate the effects of chronic hyperten-
sion and afterload reduction by nicardipine, on cardiac function, remodel-
ling and the main cardiac serotonergic receptors expression. Between 20 and 
53 weeks of age, cardiac function and anatomy was analyzed by echocardio-
graphy and blood pressure was measured by the tail- cuff method. SHRs were 
treated between 37 and 53WO by nicardipine (6mg/kg/day i.p.) (SHR- N). At 
53WO, the heart was analyzed for the expression of the following mRNAs: 
5- HT2aR, 5- HT2bR, 5- HT4R, ANP, BNP, SERCAA2, Collagen I, Collagen III 
and ß- MHC.
Between 20 and 53WO, SHRs demonstrate a severe hypertension, a LV 
hypertrophy reduced by nicardipine but no systolic function alteration. 
The diastolic function is altered as attested by the isovolumetric relaxation 
time increase. DTI at the mitral annulus identified a decrease in the early 
diastolic velocities (lateral Ea: 6.2±1.25cm/s in WKYs vs 4.16±1.27cm/s 
in SHRs, p<0.0001 and septal Ea). These indexes were not modified by 
nicardipine.
In RT- qPCR, HBP induce in SHRs 5- HT2aR(¨Cp=16.1±1.8 in WKYs vs ¨Cp=11.43±0.5 in SHRs, p=0.0001), 5- HT2bR, 5- HT4R, collagen I and III 
overexpressions. BP reduction affected mainly the 5- HT2aR (¨Cp=12.4±0.07 
in SHR- N, ¨Cp=11.4±0.2 in SHR- C, p=0.0016), collagens I and III 
expressions.
In this work, we show that SHRs develop a LV diastolic dysfunction, not 
improved by BP reduction with a preserved contractility and that chronic hyper-
tension and cardiac remodelling trigger 5- HT2aR, 5- HT2bR and 5- HT4R overex-
pressions in SHRs and that BP reduction only affects the 5- HT2aR overexpression.
